Literature DB >> 6691896

Plasma dopamine-beta-hydroxylase in neuroblastoma.

M Schöni, H Käser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6691896      PMCID: PMC1976687          DOI: 10.1038/bjc.1984.17

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  5 in total

Review 1.  Serum dopamine beta-hydroxylase.

Authors:  R M Weinshilboum
Journal:  Pharmacol Rev       Date:  1978-06       Impact factor: 25.468

2.  Photometric assay of dopamine- -hydroxylase activity in human blood.

Authors:  T Nagatsu; S Udenfriend
Journal:  Clin Chem       Date:  1972-09       Impact factor: 8.327

3.  Serum dopamine-beta-hydroxylase activity in neuroblastoma.

Authors:  M Goldstein; L S Freedman; A C Bohuon; F Guerinot
Journal:  N Engl J Med       Date:  1972-05-25       Impact factor: 91.245

4.  Serial studies of serum dopamine-B-hydroxylase and urinary vanillylmandelic and homovanillic acids in neuroblastoma.

Authors:  M A Brewster; D H Berry
Journal:  Med Pediatr Oncol       Date:  1979

5.  Serum dopamine beta hydroxylase in children with neuroblastoma.

Authors:  B B Eldeeb; S Burns; R Robinson; E M Hammond; J R Mann
Journal:  Br J Cancer       Date:  1983-01       Impact factor: 7.640

  5 in total
  1 in total

1.  Dopamine-beta-hydroxylase in patients with cystic fibrosis.

Authors:  M H Schöni; K Türler; H Käser; R Kraemer
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.